Skip to content
StockMarketAgent
Healthcare / Medical Instruments & SuppliesUpdated 2026-05-10 22:07 UTC

BVMF/C1OO34 stock hub

BVMF/C1OO34 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

BVMF/C1OO34is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
57.3B
Brazil Stock Exchange
Market data

Live price

Current market quote for this ticker.

Current price
BVMF/C1OO34
In the news

Latest news · BVMF/C1OO34

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E12.7
P25 11.3P50 14.6P75 19.6
Trailing P/E27.3
P25 15.2P50 21.5P75 27.3
ROE4.9
P25 5.3P50 12.3P75 22.5
ROIC4.3
P25 7P50 12.5P75 22.1
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All BVMF/C1OO34 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
217
Groups with data
11
Currency
USD
Showing 217 of 217 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

19
MetricValue
Country
United States
Country code
BR
Employees
15,000
Employees Change
-1,000%
Employees Change Percent
-6.25
Enterprise value
BRL 70.3B
Exchange
Brazil Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Medical Instruments & Supplies
Last refreshed
2026-05-10
Market cap
BRL 57.3B
Price
BRL 30.21
Price currency
BRL
Rev Per Employee
1,449,863.92x
Sector
Healthcare
Sic
3851
Symbol
bvmf/C1OO34
Website
https://www.coopercos.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

14
MetricValue
Earnings Yield
3.67%
EV Earnings
33.45x
EV/EBIT
20.01x
EV/EBITDA
12.43x
EV/FCF
27.33x
EV/Sales
3.46x
FCF yield
4.49%
Forward P/E
12.74x
P/B ratio
1.31x
P/E ratio
27.27x
P/S ratio
2.64x
PE Ratio10 Y
42.55x
PE Ratio3 Y
50.49x
PE Ratio5 Y
39.34x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

24
MetricValue
EBIT Margin
17.28%
EBITDA Margin
26.48%
FCF margin
11.83%
Gross margin
65.44%
Gross Profit
BRL 14.2B
Gross Profit Growth
3.23%
Gross Profit Growth Q
5.3%
Gross Profit Growth3 Y
7.19%
Gross Profit Growth5 Y
10.5%
Net Income
BRL 2.1B
Net Income Growth
-3.37%
Net Income Growth Q
25.41%
Net Income Growth3 Y
2.28%
Net Income Growth5 Y
-29.15%
Pretax Margin
14.58%
Profit Margin
9.67%
Profit Per Employee
BRL 140,174
ROA
3.64
Roa5y
3.46
ROCE
6.63
ROE
4.87
Roe5y
14.75
ROIC
4.34
Roic5y
4.93

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

22
MetricValue
Cagr1y
-34.13%
Cagr3y
-14.6%
Cagr5y
-11.09%
Div CAGR3
0%
Div CAGR5
-0.95%
EPS Growth
-3.02
EPS Growth Q
26.92
EPS Growth3 Y
1.98
EPS Growth5 Y
-29.28
FCF Growth
27.68%
FCF Growth Q
56.82%
FCF Growth3 Y
4.94%
FCF Growth5 Y
18.83%
OCF Growth
11.48%
OCF Growth Q
36.88%
OCF Growth10 Y
8.02%
OCF Growth3 Y
7.73%
OCF Growth5 Y
11.42%
Revenue Growth
5.68x
Revenue Growth Q
6.16x
Revenue Growth3 Y
7.1x
Revenue Growth5 Y
10.99x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

22
MetricValue
Asset Turnover
BRL 0.34
Assets
BRL 65.1B
Cash
BRL 654.3M
Current Assets
BRL 10.5B
Current Liabilities
BRL 7.8B
Debt
BRL 14.5B
Debt EBITDA
BRL 2.4
Debt Equity
BRL 0.33
Debt FCF
BRL 5.65
Equity
BRL 43.8B
Interest Coverage
7.44
Liabilities
BRL 21.3B
Long Term Assets
BRL 54.6B
Long Term Liabilities
BRL 13.4B
Net Cash
BRL -13.9B
Net Cash By Market Cap
BRL -24.23
Net Debt EBITDA
BRL 2.41
Net Debt Equity
BRL 0.32
Net Debt FCF
BRL 5.4
Tangible Book Value
BRL 15.3B
Tangible Book Value Per Share
BRL 78.31
WACC
8.57

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
1.34
Inventory Turnover
1.67
Net Working Capital
BRL 5.4B
Quick ratio
0.58
Working Capital
BRL 2.8B
Working Capital Turnover
BRL 28.51

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

3
MetricValue
Buyback Yield
0.92%
Dividend per share
BRL 0
Last Dividend
BRL 0

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

35
MetricValue
1Y total return
-34.11%
200-day SMA
44.85
3Y total return
-37.72%
50-day SMA
39.03
50-day SMA vs 200-day SMA
50under200
5Y total return
-44.43%
All Time High
61.92
All Time High Change
-51.21%
All Time High Date
2024-10-16
All Time Low
30.21
All Time Low Change
0%
All Time Low Date
2026-05-05
ATR
1.32
Beta
1.07
Ch YTD
-34.4
High
30.21
High52
48.05
High52 Date
2025-05-12
High52ch
-37.13%
Low
30.21
Low52
30.21
Low52 Date
2026-05-05
Low52ch
0%
Ma50ch
-22.6%
Price vs 200-day SMA
-32.64%
RSI
22.78
RSI Monthly
34.67
RSI Weekly
36.21
Sharpe ratio
-0x
Sortino ratio
0.07
Total Return
0.92%
Tr YTD
-34.4
Tr1m
-19.57%
Tr1w
-3.85%
Tr3m
-28.24%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

6
MetricValue
Operating Income
BRL 3.8B
Operating Income Growth
-2.62
Operating Income Growth Q
16.92
Operating Income Growth3 Y
8.78
Operating Income Growth5 Y
11.16
Operating margin
17.28

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
193,679,208%
Net Borrowing
-213,767,700
Shares Insiders
0.6%
Shares Institutions
106.12%
Shares Qo Q
-0.71%
Shares Yo Y
-0.92%
Short Ratio
2.61

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

59
MetricValue
Adjusted FCF
BRL 2.2B
Average Volume
30.95x
Bv Per Share
224.6
CAPEX
BRL -2B
Ch1m
-19.57
Ch1w
-3.85
Ch1y
-34.11
Ch3m
-28.24
Ch3y
-37.72
Ch5y
-44.44
Ch6m
-19.57
Change
0%
Change From Open
0
Depreciation Amortization
1,876,732,980
Dollar Volume
30.21
Earnings Date
2026-06-04
EBIT
BRL 3.8B
EBITDA
BRL 5.8B
EPS
BRL 10.51
F Score
6
FCF
BRL 2.6B
FCF EV Yield
3.66x
Financing CF
-2,499,669,040
Fiscal Year End
October
Founded
1,958
Goodwill
19,191,916,680
Graham Number
23.9881
Graham Upside
-20.6
Income Tax
BRL 1.1B
Investing CF
-1,985,277,800
Is Primary Listing
0
Last Earnings Date
2026-03-05
Last Report Date
2026-01-31
Last Split Date
2024-02-20
Last Split Type
Forward
Lynch Fair Value
BRL 5.54
Lynch Upside
-81.66
Ma150
42.93
Ma150ch
-29.63%
Ma20
40.32
Ma20ch
-25.07%
Net CF
125,716,800
Next Earnings Date
2026-06-04
Open
30.21
P FCF Ratio
22.28
P OCF Ratio
12.63
Ppne
10,401,887,140
Price Date
2026-05-05
Price EBITDA
BRL 9.96
Ptbv Ratio
3.75
Relative Volume
0.03x
Revenue
21,747,958,760x
SBC By Revenue
1.7x
Share Based Comp
369,293,100
Tax By Revenue
4.91x
Tax Rate
33.7%
Tr6m
-19.57%
Volume
1
Z Score
3.71
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does BVMF/C1OO34 pay a dividend?

Capital-return profile for this ticker.

Performance

BVMF/C1OO34 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-34.1%
S&P 500 1Y: n/a
3Y total return
-37.7%
S&P 500 3Y: n/a
5Y total return
-44.4%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns BVMF/C1OO34?

Insider, institutional, and short-interest positioning.

Institutional ownership
+106.1%
Share of float held by funds and institutions
Insider ownership
+0.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
2.6 days to cover
Y/Y dilution
-0.9%
Negative means the company is buying back shares.
Technical

BVMF/C1OO34 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
22.8
Below 30: short-term oversold
Price vs 200-day MA
-32.6%
50/200-day relationship not available
Beta (5Y)
1.07
Moves roughly with the market
Sharpe ratio
-0.00
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About BVMF/C1OO34

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvmf/C1OO34 stock rating?

bvmf/C1OO34 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvmf/C1OO34 analysis?

The full report lives at /stocks/bvmf/C1OO34/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvmf/C1OO34?

The latest report frames bvmf/C1OO34 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvmf/C1OO34 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.

bvmf/C1OO34 stock profile: metrics, valuation and analysis | دستیار هوشمند بازار سهام